Emcure Pharmaceuticals Ltd.
EMCURE
Rank in Stocks
#4336
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Share Price
$18.85
Market Cap
$3.58B
Change (1 day)
-2.91%
Change (1 year)
19.17%
Country
IN
Trade Emcure Pharmaceuticals Ltd. (EMCURE)
Category
Healthcare
Stock price history for Emcure Pharmaceuticals Ltd. (EMCURE)
Highest end of day price: $20.40 on 2026-10-01
Lowest end of day price: $15.91 on 2024-07-01
Lowest end of day price: $15.91 on 2024-07-01
Stock price history of Emcure Pharmaceuticals Ltd. from 2024 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 16.97% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.42 | -4.08% |
IN
|
